Loading...
CONMED Corporation
CNMD•NYSE
Healthcare
Medical - Devices
$50.95
$1.39(2.80%)
CONMED Corporation (CNMD) Financial Performance & Income Statement Overview
Review CONMED Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.003%
↑ 5.003%
Operating Income Growth
53.17%
↑ 53.17%
Net Income Growth
105.44%
↑ 105.44%
Operating Cash Flow Growth
33.20%
↑ 33.20%
Operating Margin
13.02%
↑ 13.02%
Gross Margin
55.46%
↑ 55.46%
Net Profit Margin
9.02%
↑ 9.02%
ROE
12.65%
↑ 12.65%
ROIC
8.51%
↑ 8.51%
CONMED Corporation (CNMD) Income Statement & Financial Overview
Review CONMED Corporation's (CNMD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $345.94M | $316.70M | $330.75M | $311.63M |
| Cost of Revenue | $147.60M | $137.71M | $157.59M | $149.65M |
| Gross Profit | $198.34M | $179.00M | $173.15M | $161.98M |
| Gross Profit Ratio | $0.57 | $0.57 | $0.52 | $0.52 |
| R&D Expenses | $13.18M | $13.56M | $14.10M | $13.59M |
| SG&A Expenses | $132.67M | $99.73M | $121.84M | $106.10M |
| Operating Expenses | $145.84M | $113.29M | $135.94M | $119.69M |
| Total Costs & Expenses | $293.44M | $250.99M | $293.54M | $269.35M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $8.86M | $9.25M | $9.59M | $9.59M |
| Depreciation & Amortization | $18.006M | $17.97M | $12.77M | $12.65M |
| EBITDA | $70.50M | $83.68M | $47.11M | $54.93M |
| EBITDA Ratio | $0.20 | $0.26 | $0.14 | $0.18 |
| Operating Income | $52.50M | $65.71M | $37.21M | $42.29M |
| Operating Income Ratio | $0.15 | $0.21 | $0.11 | $0.14 |
| Other Income/Expenses (Net) | -$8.86M | -$9.25M | -$9.59M | -$9.59M |
| Income Before Tax | $43.64M | $56.45M | $37.51M | $25.42M |
| Income Before Tax Ratio | $0.13 | $0.18 | $0.11 | $0.08 |
| Income Tax Expense | $9.89M | $7.47M | $7.54M | $5.71M |
| Net Income | $33.76M | $48.98M | $29.98M | $19.71M |
| Net Income Ratio | $0.10 | $0.15 | $0.09 | $0.06 |
| EPS | $1.09 | $1.59 | $0.97 | $0.64 |
| Diluted EPS | $1.08 | $1.57 | $0.96 | $0.63 |
| Weighted Avg Shares Outstanding | $30.85M | $30.86M | $30.81M | $30.78M |
| Weighted Avg Shares Outstanding (Diluted) | $31.11M | $31.11M | $31.11M | $31.27M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan